← Back to catalogue

Impact Rpr™ Test Kit (150 Tests)

FDA UDI

Class II (US FDA UDI)

by Alere North America, Llc

Identity

Trade Name
IMPACT RPR™ TEST KIT (150 TESTS) FDA UDI
Generic Name
Treponema pallidum reagin antibody IVD, kit, agglutination FDA UDI
Model / Reference
60C2 FDA UDI

Identifiers

Primary DI / UDI-DI
10859035006047 FDA UDI
FDA Product Code
GMQ FDA UDI
GMDN Term
Treponema pallidum reagin antibody IVD, kit, agglutination FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3820 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Treponema pallidum reagin antibody IVD, kit, agglutination

Impact Rpr™ Test Kit (150 Tests) by Alere North America, Llc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Treponema pallidum reagin antibody IVD, kit, agglutination.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 26e895c4-04e9-4897-b450-4641a80e8c0b 34 fields · synced May 29, 2026